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Abstract 
Outer membrane vesicles (OMVs) are constitutively produced by Gram-negative 
bacteria both in vivo and in vitro. These lipid-bound structures carry a range of 
immunogenic components derived from the parent cell, which are transported into 
host target cells and activate the innate immune system. Recent advances in the 
field have shed light on some of the multifaceted roles of OMVs in host-pathogen 
interactions. In this study, we investigated the ability of OMVs from two clinically 
important pathogens, Pseudomonas aeruginosa and Helicobacter pylori, to activate 
canonical and non-canonical inflammasomes. P. aeruginosa OMVs induced 
inflammasome activation in mouse macrophages, as evidenced by “speck” 
formation, as well as the cleavage and secretion of interleukin-1 and caspase-1. 
These responses were independent of AIM2 and NLRC4 canonical inflammasomes, 
but dependent on the non-canonical caspase-11 pathway. Moreover, P. aeruginosa 
OMVs alone were able to activate the inflammasome in a TLR-dependent manner, 
without requiring an exogenous priming signal. In contrast, H. pylori OMVs were not 
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able to induce inflammasome activation in macrophages. Using CRISPR/Cas9 
knockout THP-1 cells lacking the human caspase-11 homologs, caspase-4 and -5, 
we demonstrated that caspase-5 but not caspase-4 is required for inflammasome 
activation by P. aeruginosa OMVs in human monocytes. In contrast, free 
P. aeruginosa LPS transfected into cells induced inflammasome responses via 
caspase-4. This suggests that caspase-4 and caspase-5 differentially recognize LPS 
depending on its physical form or route of delivery into the cell. These findings have 
relevance to Gram-negative infections in humans and the use of OMVs as novel 
vaccines.  
 
Introduction 
Extracellular vesicles produced by Gram-negative bacteria, known as outer 
membrane vesicles (OMVs), are released during all stages of growth. Contrary to the 
long-held belief that OMVs are bacterial by-products with no biological significance, 
recent advances in the field have revealed that OMVs are in fact a form of secretion 
system, facilitating a range of biological functions, from intra-bacterial 
communication, to host colonization and immune modulation.1 It has been shown 
that OMVs interact with host target cells2, 3 and are able to transport their cargo into 
cells. In this way, OMVs serve as vehicles in the long-distance delivery of 
immunomodulatory molecules and thus act as indirect effectors between the 
pathogen and its host.  
 
OMVs contain a range of microbial-associated molecular patterns (MAMPs) that 
have the ability to activate the innate immune response, including lipopolysaccharide 
(LPS)3, 4, DNA5, 6 and peptidoglycan.2, 7 Several of these MAMPs are recognized by 
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cytoplasmic sensors capable of forming large multiprotein complexes, known as 
inflammasomes. Inflammasome activation is characterized by rapid macrophage cell 
death, termed pyroptosis, which is accompanied by the passive release of the 
mature forms of caspase-1 and interleukin-1β (IL-1β).8 These responses first require 
a “priming” signal (“signal one”), generally involving the activation of Toll-like receptor 
(TLR) signaling, which triggers the activation of the transcription factor nuclear 
factor-κB (NF-κB) and subsequent production of pro-inflammatory cytokines, 
including pro-IL-1β.9 “Signal two” corresponds to a danger signal that activates 
inflammasome complex formation, resulting in recruitment of the adapter molecule 
ASC (apoptosis-associated speck-like protein containing CARD) and cleavage of 
caspase-1 and IL-1β into their mature forms.10 It is the nature of this second signal 
that dictates the type of inflammasome activated. Indeed, the absent in melanoma-2 
(AIM2) inflammasome is activated in response to foreign cytosolic DNA; the NOD-
like receptor family CARD domain-containing protein 4 (NLRC4) inflammasome is 
activated by cytosolic flagellin or type III effector proteins;11 and the NACHT, leucine-
rich repeat and PYD-domain-containing protein 3 (NLRP3) inflammasome responds 
to a range of microbial and host stimuli.12 A non-canonical inflammasome pathway 
was also recently described in which murine caspase-11 is activated by directly 
binding to cytosolic LPS from some Gram-negative bacteria but not others. The 
human homologs were identified as caspase-4 and -5,13 with caspase-4 required for 
responses to transfected free LPS, whereas both caspases were required for 
maximal responses to Salmonella enterica Typhimurium infection.14-16  
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OMVs from the opportunistic pathogen Pseudomonas aeruginosa harbor 
multiple MAMPs capable of activating inflammasome signaling pathways, such as 
LPS, DNA, flagellin. In the current study, we sought to identify the inflammasome 
pathway(s) induced by P. aeruginosa OMV-bound LPS and DNA. We show that 
P. aeruginosa OMVs are able to provide both signal 1 and 2 required for 
inflammasome activation. Importantly, we identified murine caspase-11, but not 
AIM2 or NLRC4, as being required for IL-1 responses and cell death in response to 
P. aeruginosa OMVs. Furthermore, for the first time we have demonstrated that 
caspase-5 and not caspase-4 is required for OMV activation of the non-canonical 
inflammasome in human monocyte-derived macrophages. Collectively, the findings 
identify LPS as being the major MAMP responsible for inflammasome activation by 
P. aeruginosa OMVs and suggest that in human macrophages, OMV-associated 
LPS may be recognized differently to either free LPS or live bacteria.  
 
Results 
P. aeruginosa OMVs induce ASC speck formation in macrophages 
To investigate inflammasome activation by P. aeruginosa OMVs, we first used 
NLRP3-deficient macrophages stably reconstituted with cerulean-tagged ASC and 
NLRP3-Flag (ASC-cerulean IMACs17), which obviates the need for signal 1 in 
inflammasome activation.18 These ASC-cerulean IMACs can therefore be used to 
visualize the ability of a given stimulus to promote inflammasome activation, as 
assessed by ASC “speck” formation18, 19 (Supplementary Movie 1). Live cell imaging 
of these cells showed uptake of OMVs (Supplementary Movies 2-6), followed by 
oligomerization of the ASC molecules into discrete specks at approximately 14 h 
post OMV-treatment (Figure 1a; Supplementary Movie 1). As reported previously19, 
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one speck was generally observed in each individual cell (Supplementary Movie 7). 
The number of specks in OMV-treated cells was significantly greater than the 
untreated control imaged under the same conditions (Figure 1b; p = 0.0142; 
Supplementary Movies 2-6), thus demonstrating that P. aeruginosa OMVs are able 
to induce ASC speck formation in macrophages. 
 
P. aeruginosa OMVs induce caspase-1 and IL-1 processing in macrophages 
via an ASC-dependent pathway 
ASC is required for the formation of inflammasome complexes, which lead to the 
processing of caspase-1 and IL-1β into their mature forms.10 Cells were primed with 
Pam3CSK4 for 4 h, rather than with LPS, to avoid activation of the caspase-11 
inflammasome from the priming signal. Stimulation of wild type (WT) and Asc-/- 
primary bone marrow-derived macrophages (BMDMs) with P. aeruginosa OMVs for 
24 h resulted in loss of IL-1β (Figure 2a) and IL-18 (Supplementary Figure 1a) 
responses in Asc-/- BMDMs, but no changes in TNF-α nor IL-6 production 
(Supplementary Figure 1b and c). Furthermore, stimulation with P. aeruginosa OMVs 
was shown to promote the maturation of caspase-1 and IL-1β and release into the 
culture supernatants of WT but not Asc-/- BMDMs (Figure 2b). The pro-forms of 
caspase-1 and IL-1β were detectable in both WT and Asc-/- cell lysates, indicating 
that the difference in processing of the mature forms was not due to varying amounts 
of pro-form present (Figure 2b). As we have shown that P. aeruginosa OMVs contain 
DNA on their surfaces,20 we sought to determine whether this DNA may be involved 
in inflammasome activation. For this, we stimulated cells with DNase-treated and 
untreated P. aeruginosa OMVs. However, no differences were observed in IL-1β, 
caspase-1 or IL-18 responses for WT BMDMs stimulated with DNase-treated OMVs, 
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suggesting that DNA is unlikely to be involved in inflammasome activation (Figure 
2a; Supplementary Figure 1a), although DNA within OMVs and protected from 
digestion could not be excluded. Consistent with a lack of any role of DNA, we also 
showed that in contrast to P. aeruginosa OMVs, those from Helicobacter pylori that 
also contain DNA (data not shown), were unable to activate the inflammasome 
(Supplementary Figure 2a and b). H. pylori OMVs induced low levels of TNF-α 
production in mouse BMDMs compared to P. aeruginosa OMVs (Supplementary 
Figure 2c), consistent with the low capacity for H. pylori LPS to activate TLR4.21 
These data demonstrate that P. aeruginosa OMVs mediate inflammasome activation 
of pro-inflammatory cytokine responses via an ASC-dependent pathway that is 
unlikely to involve DNA recognition. 
 
P. aeruginosa OMVs provide signal 1 and 2 for inflammasome activation  
P. aeruginosa OMVs induced IL-1, TNF-α and IL-6 production (Figure 2a; 
Supplementary Figure 1b and c), as well as pro-IL-1 synthesis (Figure 2b), in the 
absence of any priming with the TLR2 agonist, Pam3CSK4. This indicates that 
P. aeruginosa OMVs have the ability to prime inflammasome activation without the 
need for an exogenous signal. To determine the role of TLR signaling in this priming, 
we used myeloid differentiation primary response gene 88 (MyD88) and TIR-domain-
containing adapter-inducing interferon-β (TRIF) double knockout IMACs 
(Myd88-/-/Tri-/-), which lack the ability to respond to all major TLR agonists.22 
Myd88-/-/Trif-/- IMACs failed to elicit any IL-1β, TNF-α or IL-6 production in response 
to stimulation with P. aeruginosa OMVs (Figure 3), indicating that the priming signal 
provided by these OMVs is TLR-dependent.  
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We next sought to determine the TLR agonist(s) that may be responsible for 
P. aeruginosa OMVs priming of the inflammasome. For this, we used IMACs 
deficient in the Mal adapter molecule (Mal), required for TLR2 and -4 signaling23 to 
two major MAMPs of Gram-negative bacteria, lipoproteins24 and LPS25, respectively. 
Mal-/- IMACs displayed decreased TNF-α and IL-6 production in response to OMVs 
when compared with WT IMACs (Supplementary Figure 3). We found that both 
TLR2 and TLR4 are required for cytokine responses to P. aeruginosa OMVs 
(Supplementary Figure 4). Nevertheless, in common with the situation observed for 
Mal-/- IMACs (Supplementary Figure 3), deletion of either Tlr2 or Tlr4 did not 
completely abrogate cytokine responses to these OMVs. Furthermore, pre-treatment 
of Mal-/- IMACs with an antagonist (ODN 2088) of the DNA sensor TLR926 had only a 
weak effect on cytokine responses to OMVs, yet this treatment completely abrogated 
responses to a TLR9 agonist (Supplementary Figure 5). DNAse treatment of OMVs 
had no effect on responses to either WT or Mal-/- IMACs (Supplementary Figures 3 
and 5), suggesting that DNA is unlikely to account for the priming activity of 
P. aeruginosa OMVs. Taken together, the data suggest that TLR2 and TLR4 
agonists, such as lipoproteins and LPS, but not TLR9 recognition of DNA, contribute 
to the priming observed in response to P. aeruginosa OMVs. It is likely that other 
TLR agonist(s) are also important.  
 
P. aeruginosa OMVs activate the non-canonical inflammasome in mouse 
macrophages 
We have shown that P. aeruginosa OMVs activate the inflammasome in mouse 
macrophages via an ASC-dependent mechanism (Figure 2a,b). To define the 
specific inflammasome(s) involved, IMACs lacking each of the key sensors required 
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for canonical inflammasome activation by Gram-negative bacteria (that is, Aim2, 
Nlrp3 and Nlrc4) were treated with OMVs (Figure 4). No differences were observed 
in IL-1 and IL-18 responses in the Aim2-/- and Nlrc4-/- IMACs when compared with 
WT cells (Figure 4a,b). In contrast, decreased IL-1β and IL-18 production were 
observed in the Nlrp3-/- IMACs, suggesting that NLRP3 plays a role in inflammasome 
activation by P. aeruginosa OMVs (Figure 4c). 
 
We then examined the role of the non-canonical inflammasome27 in response to 
OMVs using Casp11-/- primary BMDMs. Compared to WT primary BMDMs, those 
from Casp11-/- mice produced reduced levels of IL-1β and IL-18 in response to either 
P. aeruginosa OMVs or transfected purified P. aeruginosa LPS, but responded 
normally to the canonical inflammasome agonist, polydA:dT (Figure 5a; 
Supplementary Figure 6a). Significantly reduced levels of cell death occurred in the 
Casp11-/- BMDMs, stimulated with either P. aeruginosa OMVs or transfected LPS, 
but not in those stimulated with polydA:dT (Figure 5b). Casp11-/- BMDMs responded 
normally to TLR stimulation (Supplementary Figure 6b and c) and pro-forms of 
caspase-1 and IL-1β were observed in both WT and Casp11-/- BMDMs treated with 
P. aeruginosa OMVs. (Figure 5c). Importantly, mature forms of caspase-1 and IL-1β 
were detected in the supernatants of WT but not Casp11-/- BMDMs (Figure 5c). 
Interestingly, H. pylori OMVs did not induce production of IL-1β (Figure 5a) or IL-18 
(Supplementary Figure 5a), nor caspase-1 and IL-1 processing (Figure 5c) in either 
WT or Casp11-/- BMDMs (Figure 5c). Furthermore, no differences were observed in 
cell death (Figure 5b), TNF- and IL-6 responses (Supplementary Figure 5b and c) 
between WT and Casp11-/- BMDMs treated with H. pylori OMVs.  
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Taken together, the data demonstrate that in common with OMVs from 
enterohemorrhagic Escherichia coli,3 those from P. aeruginosa are recognized by 
cytosolic caspase-11, which results in the activation of the non-canonical 
inflammasome. However, as shown by the findings for H. pylori OMVs, the ability to 
activate caspase-11 is not common to OMVs from all Gram-negative bacteria.  
 
P. aeruginosa OMVs activate the caspase-5 inflammasome in human THP-1 
monocytes 
The human homologs of murine Casp11 are CASP4 and CASP5, which have been 
shown to mediate non-canonical inflammasome activation in human monocytes.13, 16 
Although it is thought that there is redundancy between the two human caspases,13 
our recent findings showed that caspase-4 was required for non-canonical 
inflammasome activation by both free transfected LPS and S. Typhimurium bacteria, 
whereas caspase-5 was required for responses to S. Typhimurium and not free 
LPS.14 We addressed the respective roles of these caspases in responses to 
P. aeruginosa OMVs using human THP-1 monocytes targeted by CRISPR/Cas9 with 
guides specific to either CASP4, CASP5 or both CASP4 and CASP5.14 Cas9-only 
cells with no CRISPR deletion were used as controls. Consistent with Baker et al.14, 
we observed decreases in IL-1β production and cell death in response to transfected 
LPS in both CASP4-/- and CASP4-/-CASP5-/-, but not in CASP5-/- monocytes. As was 
previously reported for S. Typhimurium,14 stimulation with live P. aeruginosa bacteria 
resulted in decreased IL-1β production and cell death in CASP4-/-, CASP5-/- and 
double knockout monocytes relative to WT cells (Figure 6a-c). Interestingly, 
however, significant levels of IL-1β production and cell death were still observed in 
the double knockout monocytes in response to either P. aeruginosa LPS or live 
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bacteria (Figure 6c). This varies with our previous findings for S. Typhimurium14, in 
which the effects of the knockout were much greater, and may reflect the differences 
in the bioactivities of P. aeruginosa LPS versus those of Gram-negative bacteria, 
such as S. Typhimurium and E. coli.  
 
In response to P. aeruginosa OMVs, we observed reduced IL-1β production and cell 
death in CASP5-/- and double knockout monocytes (Figure 6b,c) but not CASP4-/- 
cells (Figure 6a). Similar findings were observed when phorbol 12-myristate 13-
acetate (PMA) was used to differentiate the THP-1 monocytes to monocyte-derived 
macrophages (Supplementary Figure 7). Thus, for the first time we have shown that 
OMVs from P. aeruginosa selectively activate the non-canonical inflammasome in 
human monocytes through caspase-5.  
 
Discussion 
In this study, we have demonstrated the activation of the non-canonical 
inflammasome by OMVs from the opportunistic pathogen P. aeruginosa in both 
murine and human systems. Furthermore, we have found that in human cells, OMV-
associated LPS is sensed by caspase-5 but not caspase-4, leading to IL-1β 
secretion and cell death.  
 
We demonstrated that OMVs derived from P. aeruginosa provide both signal 1 and 2 
required for inflammasome activation, and that signal 1 is TLR-dependent. We next 
sought to identify the inflammasome activated by P. aeruginosa OMVs. Although it 
has been suggested that P. aeruginosa OMVs may be sensed by caspase-11,3 this 
has not been thoroughly investigated. P. aeruginosa is known to activate the NLRC4 
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and NLRP3 inflammasomes,28, 29 whereas DNA carried by OMVs may have the 
potential to activate the AIM2 inflammasome.30 Therefore, we investigated the roles 
of the NLRP3, NLRC4, AIM2 and caspase-11 inflammasomes in response to 
P. aeruginosa OMVs. Our findings demonstrate that P. aeruginosa OMVs mediate 
IL-1 processing in a caspase-11-, NLRP3- and ASC-dependent manner. This is in 
agreement with the finding that NLRP3/ASC are required for caspase-1 and IL-1β 
processing upon caspase-11 activation.31 Further work is required to determine 
whether NLRP3 is downstream to caspase-11 activation by OMVs.  
 
Given that caspase-11 is cytoplasmic, it is evident that OMVs are present the 
cytoplasm in macrophages, rather than in the endosomal compartment. Previously, 
we showed in epithelial cells that H. pylori and P. aeruginosa OMVs are located in 
early endosomes within 1 h of cell entry.2 It is possible that caspase-11 recognition 
of OMV-associated LPS in macrophages also requires escape from the early 
endosome into the cytoplasm, suggesting that OMVs or their LPS are not subject to 
complete lysosomal degradation.  
 
The finding that H. pylori OMVs do not activate the inflammasome is consistent with 
studies showing that H. pylori possesses a modified form of LPS with low biological 
activity21, 27, resulting in LPS that is likely to be poorly recognized by caspase-11. 
This finding highlights the differences in the cargo carried by OMVs from different 
bacterial species, which in turn, have differing effects on innate immune responses.  
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The sensing of OMVs by the non-canonical inflammasome sensors in human cells, 
namely caspase-4 and -5,13 have not been thoroughly examined previously. A recent 
study showed that aggregates of LPS, as well as OMVs from Neisseria meningitidis, 
bound to caspase-4.32 We have previously shown that caspase-4 is required for 
sensing of free LPS from S. Typhimurium, however, both caspase-4 and -5 are 
involved in the sensing of LPS present in live bacteria.14 The current study shows 
that P. aeruginosa OMVs activate the non-canonical inflammasome in human cells in 
a caspase-5-dependent but caspase-4-independent manner. While the reason 
behind this is unclear, it suggests that OMVs present LPS to the cytosol differently to 
either free LPS or live bacteria.  
 
This study provides new insights into the previously uncharacterized role of OMVs in 
non-canonical inflammasome activation in human cells. It also provides a molecular 
basis for the known “self-adjuvanting” properties of OMVs which makes them 
effective at inducing cellular and humoral immune responses and thus excellent 
candidate vaccines. 1, 33 Moreover, we suggest that the findings are likely to be 
relevant to the pathogenesis of Gram-negative sepsis in human hosts as mice 
lacking caspase-11, but not those lacking caspase-1 alone, have been shown to be 
protected in a model for endotoxic shock.34 Finally, the discovery that OMVs are 
sensed by caspase-5 raises the potential of investigating therapeutic targets to 
caspase-5 to prevent the development of sepsis.  
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Methods 
Bacterial culture and OMV isolation  
P. aeruginosa PA103 ΔpilA35 and H. pylori 2517 were cultured as described 
previously. Briefly, OMVs were harvested from mid-exponential phase and cultures 
pelleted by centrifugation at 4 000 x g, for 40 min at 4 ◦C (Heraeus Multifuge 3SR, 
ThermoScientific, Melbourne, Australia). Supernatants were filtered through 0.22-
µm-pore-size filters (Millipore, Melbourne, Australia). OMVs were isolated by 
ultracentrifugation, as described previously.7, 36 The pellets were washed in PBS by 
ultracentrifugation, re-suspended in PBS and stored at -80 ◦C. OMV protein 
concentrations were quantified using the Bradford Protein Assay (BioRad, New 
South Wales, Australia). 
 
Immortalized cell cultures  
Stably transfected ASC-cerulean,17 wild type (WT),37 Myd88/Trif-/-,22 Mal-/-,38, Tlr2-/-, 
Aim2-/-,30 Nlrp3-/-,37 and Nlrc4-/-,37 C57/BL6 mouse immortalized macrophages were 
cultured in DMEM (Gibco, Melbourne, Australia) supplemented with 10 % fetal 
bovine serum (FBS; Gibco) and 1 % penicillin/streptomycin (P/S; Gibco). 
CRISPR/Cas9 knockout CASP4-/-, CASP5-/-, CASP4/5-/- and Cas9-only THP-1 
monocytes were generated and confirmed in detail, as described previously.14 These 
cells were cultured in RPMI (Gibco) supplemented with 10 % FBS and 1 % P/S. To 
generate MDMs, monocytes were differentiated with 20 % PMA (phorbol 12-
myristate 13-acetate; Sigma, St. Louis, Missouri) for 24 h. IMACs and THP-1 cells 
were seeded at 1 x 106/ml in 96-well plates. The following day, media was replaced 
with the appropriate antibiotic-free media. 
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Primary BMDMs  
Bone marrow was collected from C57BL/6 WT, Asc-/-, Tlr4-/- and Casp11-/- mice and 
the cells differentiated in DMEM (Gibco) supplemented with 10 % FBS, 1 % P/S and 
20 % L929 conditioned media.39 The media were replenished with a further 20 % 
L929 conditioned media on day 4. After 7 days, the macrophages were scraped in 
ice-cold PBS and seeded at 2 x 106/ml in 6-well plates.  
 
Live cell imaging  
The day prior to imaging, ASC-cerulean cells were seeded at 2 x 105/ml in 200 μl in 
μ-slide 8-well chambers (Ibidi, Munich, Germany). Cells were incubated with 
P. aeruginosa OMVs (20 μg protein per well) that had been labeled with an Alexa 
Fluor® 647 protein labeling kit (Molecular Probes, Eugene, Oregon) according to the 
manufacturer’s instructions. This technique labels OMV-bound proteins.7 Imaging 
was performed on a Lieca TCS Sp5 confocal microscope (Lieca Microsystems, 
Wetzler, Germany) in a chamber set to 37◦C and 5 % CO2 for 15-16 h. Images were 
taken every 15 mins. Images are deconvoluted Z-stacks by overlapping tile scanning 
processed using Imaris x64 7.6.5. 
 
Cell stimulations  
Cells were primed with 1 μg/ml Pam3CSK4 (Pam3CysSerLys4, InvivoGen, San 
Diego, California) for 4 h, followed by stimulation with OMVs (50 μg protein/ml) for 24 
h.7 OMVs were treated or not with TURBO® DNase I (Ambion, New South Wales, 
Australia) for 1 h. As controls, the following compounds were transfected into cells 
using Lipofectamine® 2000 (Invitrogen), according to the following concentrations 
and times: polydA:dT (1 μg/ml; InvivoGen), 4 h; ODN 2088 TLR9 antagonist (3 μM; 
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InvivoGen), 30 min; CpG (3 μM; InvivoGen), 8 h; or P. aeruginosa 10 LPS (100 
ng/ml; Sigma), 24 h. Cells were also treated with the following controls: nigericin (20 
μM; InvivoGen), 2 h; or flagellin (250 ng/ml; Sigma), 6 h.  
 
Bacterial culture and infection  
P. aeruginosa PA103 ΔpilA35 bacteria were grown to mid-log phase, washed in PBS, 
re-suspended in DMEM and added to cells at a multiplicity of infection (MOI) = 10. 
After 1 h, 10 μg/ml tetracycline was added to kill any non-internalized bacteria, 
followed by incubation for a further 23 h.  
 
Enzyme-linked immunosorbent assays (ELISA) and cytotoxicity assays  
Cell culture supernatants were assayed for mouse IL-1β, TNF-α or IL-6 according to 
the manufacturer’s instructions (BD Biosciences, Franklin Lakes, New Jersey). 
Assays for IL-18 and human IL-1β were performed using kits from ELISAkit 
(Melbourne, Australia). LDH release was measured using the CytoTox96® Non-
Radioactive Cytotoxicity Assay (Promega, Madison, Wisconsin). THP-1 monocytes 
were stained with propidium iodide (PI) (Life Technologies) at 1 μg/mL in a 5 % FCS-
PBS solution, followed by quantification of live and dead cells by flow cytometry 
(FACSCantoTM II, BD Biosciences). Data were analyzed using Kaluza® Flow 
Analysis Software (Beckman Coulter, Melbourne, Australia).  
 
Immunoblot analysis  
Supernatants were concentrated using StrataClean resin (Agilent Technologies, 
Melbourne, Australia), as per the manufacturer’s instructions. Cell lysates were 
prepared in 200 μl LDS buffer with Reducing Agent (Invitrogen). Proteins were 
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resolved on NuPAGE 4-12 % Bis-Tris Protein Gels (Invitrogen), using NuPAGE MES 
SDS running buffer (Invitrogen), and transferred onto polyvinylidene difluoride 
(PVDF) membranes using a wet transfer system at 100 V for 1 h. Membranes were 
blocked in 5 % (w/v) milk powder in TBS-T (50 mM Tris-HCL, pH 7.6, 150 mM NaCl 
and 0.1 % (v/v) Tween-20) or Odyssey buffer (LI-COR, Lincoln, Nebraska), as 
appropriate, for 2 h at room temperature (RT), followed by incubation with primary 
antibodies diluted in 1 % milk powder in TBS-T or Odyssey buffer (LI-COR) overnight 
at 4◦C. Membranes were then washed in TBS-T and incubated with the appropriate 
secondary antibody diluted in 1 % milk powder in TBS-T or Odyssey buffer (LI-COR), 
for 1 h at RT. Mouse monoclonal anti-caspase-1 p20 (1:1 000; Adipogen, San Diego, 
California) was added followed by horseradish peroxidase (HRP)-conjugated rabbit 
anti-mouse antibody (1:2 000; DAKO, Santa Clara, California) and developed using 
LumiGLO® ECL detection reagent (Cell Signaling, Danvers, Massachusettes). 
Biotinylated goat anti-mouse IL-1β p17 (1:2 000; R&D Systems, Northeast, 
Minneapolis) was added, followed by streptavidin-conjugated Alexa Fluor® 680 
(1:2 000; Molecular Probes) and developed on an Odyssey CLx Imager (LI-COR). 
Rat anti-α-tubulin antibody (1:1 000; Abcam, Cambridge United Kingdom) was added 
followed by goat anti-rat-IRDye800 secondary antibody (1:3 000; Rockland, Limerick, 
Pennsylvania) and developed on an Odyssey CLx Imager (LI-COR).  
 
Statistical analysis  
Data analysis was performed using Microsoft® Excel 2010 and GraphPad PRISM® 6. 
All data are presented as means ± SEM. Statistical analyses were performed using 
the 2-way analysis of variance (ANOVA), unless otherwise stated.  
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Figure Legends 
Figure 1. P. aeruginosa OMVs induce ASC speck formation in mouse macrophages. 
(a) ASC-cerulean IMACs (blue) treated with fluorescently-labeled OMVs (red). OMVs 
were labeled using the Alexa Fluor® 647 Protein Labeling Kit (Invitrogen) prior to 
addition to cells. Times post-OMV addition are indicated. Arrows highlight cells that 
have taken up OMVs and subsequently formed ASC specks. (b) Non-stimulated 
ASC-cerulean IMACs imaged under the same conditions and time points as the 
OMV-treated sample, showing a lack of ASC speck formation. Cell outline at T=0 is 
shown in the bright field image (BF). Scale bar = 10 μm. (c) Number of ASC specs 
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formed after 14 hours of imaging in non-stimulated (NS) or cells stimulated with 
OMVs in 16 fields of view; n=2 independent experiments per treatment, ± SEM. *p = 
0.0142 (unpaired t-test).  
 
Figure 2. P. aeruginosa OMVs activate the inflammasome via ASC in mouse 
BMDMs. (a) IL-1β production in WT vs Asc-/- BMDMs stimulated with OMVs ± 
DNase-treatment for 24 h. Pam3CSK4 priming is indicated with a “–” (unprimed) or 
“+” (primed) as shown. PolydA:dT was used as a positive control for inflammasome 
activation. n=3 biological replicates, ± SEM. ****p < 0.0001.  (b) Western blots show 
mature and pro-forms of caspase-1 and IL-1β in the supernatant or lysate as 
indicated. Pam3CSK4 priming is indicated with a “–” (unprimed) or “+” (primed) as 
shown. The α-tubulin loading control shown for cell lysates. Western blots are 
representative of 3 biological replicates.  
 
Figure 3. P. aeruginosa OMVs are self-priming in a TLR-dependent manner. (a) 
IL-1β, (b) TNF-α and (c) IL-6 production in non-primed Myd88-Trif-/- compared to WT 
IMACs, in response to OMVs ± DNase-treatment. PolydA:dT-treated cells were 
primed with Pam3CSK4 for 4 h prior to stimulation. ND = not detected. n=3 biological 
replicates, ± SEM. ****p < 0.0001.  
 
Figure 4. P. aeruginosa OMVs induce inflammasome activation via an NLRP3-
dependent but AIM2/NLRC4-independent mechanism. WT versus (a) Aim2-/-, (b) 
Nlrc4-/- and (c) Nlrp3-/- IMACs, showing IL-1β and IL-18 production in response to 
OMVs. Controls include polydA:dT, flagellin (Flag) or nigericin (Nig) for the AIM2, 
NLRC4 and NLRP3 inflammasomes, respectively. Pam3CSK4 priming is indicated 
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with a “–” (unprimed) or “+” (primed) as shown. n=3 biological replicates, ± SEM. *p < 
0.05, ****p < 0.0001.  
 
Figure 5. P. aeruginosa OMVs induce non-canonical inflammasome activation via 
caspase-11 in mouse BMDMs. (a) WT and Casp11-/- BMDMs were stimulated with 
P. aeruginosa OMVs (P. a OMVs) or H. pylori OMVs (H. p OMVs). Controls include 
polydA:dT and P. aeruginosa LPS (P. a LPS) to activate the AIM2 or caspase-11 
inflammasomes, respectively. Pam3CSK4 priming is indicated with a “–” (unprimed) 
or “+” (primed) as shown. (b) Cell death was determined by % LDH release. (c) 
Western blots show mature and pro-forms of caspase-1 and IL-1β in supernatants or 
lysates as indicated, with α-tubulin loading control shown for cell lysates. Pam3CSK4 
priming is indicated with a “–” (unprimed) or “+” (primed) as shown. n=3 biological 
replicates, ± SEM. **p < 0.01, ***p < 0.001, ****p < 0.0001. Western blots are 
representative of 3 biological replicates.  
 
Figure 6. P. aeruginosa OMVs activate the non-canonical inflammasome in human 
cells via caspase 5, but not caspase-4, in THP-1 monocytes. IL-1β and cell death (% 
PI) are shown for wild type Cas9-expressing THP-1 cells versus (a) CASP4-/-, (b) 
CASP5-/- and (c) CASP4-/-/5-/- THP-1 monocytes. Pam3CSK4 priming is indicated 
with a “–” (unprimed) or “+” (primed). PolydA:dT, P. aeruginosa LPS (P. a LPS) and 
live whole P. aeruginosa (live P. a) served as controls for the AIM2, capase-4 and 
caspase-5 inflammasomes, respectively. n=3 biological replicates, ± SEM.  
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
 
 
 
 
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
 
